Compare American Financial Group Inc (AFG) vs DexCom, Inc. (DXCM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Financial Group Inc vs DexCom, Inc. — how do they compare? American Financial Group Inc trades at $144.65 (market cap $11.97B), while DexCom, Inc. trades at $90.66 (market cap $33.79B). The key difference: DexCom, Inc. is far larger — about 2.8× American Financial Group Inc's market cap, and American Financial Group Inc pays a 2.44% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| AFG | DXCM | |
|---|---|---|
Market Cap | $11.97B | $33.79B |
Sector | Financials | Health |
52-Week High | $148.71 | $90.80 |
52-Week Low | $124.18 | $54.84 |
Enterprise Value | $12.35B | $33.24B |
Dividend Yield | 2.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
American Financial Group (AFG) trades at $144.77, up 0.63% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q2 2026 earnings of $2.82 per share, beating estimates, driven by property and casualty underwriting and investment income. Revenue for 2025 was $8.12 billion with a net income margin of 10.37%, while 2026 projections show improved profitability. A dividend of $0.88 per share is scheduled for payment in July 2026.
AFG presents a positive outlook with analyst consensus price target of $160.67, implying potential upside. Strengths include consistent earnings beats and robust ROE of 20.41%. Risks involve earnings volatility, as seen in Q1 2026 miss, and competitive insurance market pressures. Institutional activity is mixed, with some reducing holdings while others increase positions. The stock is a hold for growth-oriented investors monitoring earnings consistency.
DXCM trades at $91.00, up 3.82% today and near its 52-week high, with bullish technical signals from moving averages and strong fundamentals. Recent Q2 2026 earnings beat expectations with EPS of $0.70 versus $0.61 expected, driven by 13% revenue growth and margin expansion. The company raised full-year 2026 guidance, reflecting robust demand for continuous glucose monitors.
The outlook is positive due to sustained revenue growth, profitability improvements, and analyst consensus favoring buys. Risks include competitive pressures and potential regulatory scrutiny, but institutional ownership trends and earnings momentum support a constructive view for investors seeking exposure to medical technology.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About American Financial Group Inc
American Financial Group Inc is a holding company that is engaged primarily in property and casualty insurance services. The company has a focus on specialized commercial products for businesses. American also has annuity operations that are focused on sales of traditional fixed and fixed-indexed annuities in the education, bank, and individual markets. American's insurance operations are conducted through the Great American Insurance Group. The group writes business in all 50 of the United States, primarily through independent agents and brokers.
Read more on AFG →About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →
